Caco-2 cell culture as a model for Famotidine absorption

被引:7
作者
Degim, Z [1 ]
Unal, N
Essiz, D
Abbasoglu, U
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06330 Ankara, Turkey
[2] Food & Mouth Dis Inst, Ankara, Turkey
[3] Ankara Univ, Fac Vet, Dept Pharmacol & Toxicol, TR-06100 Ankara, Turkey
[4] Gazi Univ, Fac Pharm, Dept Microbiol, Ankara, Turkey
关键词
Caco-2; Famotidine; HPLC; microspheres; poly(lactide-co-glycolide);
D O I
10.1080/10717540590889664
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to determine penetration properties of Famotidine fro the formulations through colon adenocarcinoma (Caco)-2 cell monolayers and to compare in vitro with in vivo test results. It also aimed to determine the effect of particle size on the penetration properties of Famotidine when microsphere formulations were used. Famotidine was chosen as a model drug and Caco-2 cell culture model was used. Biodegradable Famotidine microspheres of poly(lactide-co-glycolide)(PLGA) polymer (50:50) were prepared by using multiple emulsion technique. Microspheres were coded according to their particle size and polymer[LHIV: 60 mum Famotidine-PLGA(high viscosity), SHIV: 6 mum Famotidine PLGA(high viscosity), LLIV: 60 mum Famotidine-PLGA (low viscosity), SLIV: 6 mum Famotidine-PLGA (low viscosity)]. Famotidine solution(5 mg/ml) and microsphere formulations were administered orally to mice and blood drug levels were determined and compared with the Caco-2 cell experiments. Permeability values of Famotidine through Caco-2 cells from various formulations were determined (log k(solution)=7,274+/-0,010, log k(SHIV)=-3,884+/-0,033, log k(LHIV)=-2,300+/-0,009, log k(SLIV)=-4,076+/-0,208, log k(LLIV)=3,525+/-0,045). Our results showed that H-2 receptor antagonists alter the barrier properties of the Caco-2 cell monolayer by causing an increment in the tightness of the tight junctions. Therefore, amount of the H-2 receptor antagonist-like drug at the site of action was found to be important as well as polymer type and particle size of microspheres for drug permeation. Permeation of the drug was lower when higher amounts of Famotidine were present at the diffusion site. A controlled release dosage form of H-2 receptor antagonist-like drugs may be beneficial for long-term treatments.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 19 条
[1]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P305
[2]   Controlled release of β-estradiol from PLAGA microparticles:: The effect of organic phase solvent on encapsulation and release [J].
Birnbaum, DT ;
Kosmala, JD ;
Henthorn, DB ;
Brannon-Peppas, L .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (03) :375-387
[3]   Comparison of passive drug transport through Caco-2 cells and artificial membranes [J].
Camenisch, G ;
Folkers, G ;
vandeWaterbeemd, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 147 (01) :61-70
[4]   CHARACTERIZATION OF A NEWLY ISOLATED CACO-2 CLONE (TC-7), AS A MODEL OF TRANSPORT PROCESSES AND BIOTRANSFORMATION OF DRUGS [J].
CARO, I ;
BOULENC, X ;
ROUSSET, M ;
MEUNIER, V ;
BOURRIE, M ;
JULIAN, B ;
JOYEUX, H ;
ROGUES, C ;
BERGER, Y ;
ZWEIBAUM, A ;
FABRE, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (02) :147-158
[5]   Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique [J].
Castellanos, IJ ;
Carrasquillo, KG ;
López, JD ;
Alvarez, M ;
Griebenow, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (02) :167-178
[6]   Nonisothermal stability tests of famotidine and nizatidine [J].
Degim, Z ;
Agabeyoglu, I .
FARMACO, 2002, 57 (09) :729-735
[7]  
Degim Z., 2001, WORLD C PHARM PHARM, P53
[8]   The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent [J].
Desai, MP ;
Labhasetwar, V ;
Walter, E ;
Levy, RJ ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1568-1573
[9]   Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium [J].
Foster, KA ;
Yazdanian, M ;
Audus, KL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (01) :57-66
[10]   Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists [J].
Gan, LSL ;
Yanni, S ;
Thakker, DR .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :53-57